TACSTD2 and breast carcinoma: Trophoblast cell surface antigen 2 (Trop-2), a transmembrane glycoprotein, is expressed in all subtypes of breast cancer, especially in more than 85% of triple-negative breast cancer (TNBC) [1], where its high expression is associated with a poor prognosis [2,3].